Skip to main content
. Author manuscript; available in PMC: 2008 Dec 15.
Published in final edited form as: Pharmacol Biochem Behav. 2008 Mar 28;90(3):387–393. doi: 10.1016/j.pbb.2008.03.013

Table 2.

Training and experimental protocol for the Go/No-go procedure used in Experiment 2.

Stage and days per stage 1 Conditions Mean (±SEM) sessions to completion
1 (2 sessions) Go trials only: Nose pokes during the light cue reinforced with 19.95 µl sucrose2. Each session consisted of 60 Go trials with cue periods of 30 s. Female D4KO: 5.4 ± 0.7
Female WT: 6.4 ± 1.0
Male D4KO: 6.0 ± 0.6
Male WT: 4.8 ± 0.4
2 (2 sessions) Go trials only. Light cue period reduced to 10 s. Female D4KO: 3.0 ± 0.44
Female WT: 3.4 ± 0.9
Male D4KO: 3.8 ± 1.4
Male WT: 2.6 ± 0.4
3 (15 sessions) No-go trials introduced: 19.95 µl sucrose delivered if no nose pokes occurred during 5-s tone cue. Each session consisted of 30 Go trials and 30 No-go trials with cue periods of 5 s.
1

Notes. For Stages 1–2, mice advanced to the next stage after completing 2 consecutive sessions with 30 or more trials completed within 40 minutes.

2

The side location of the cup delivering the reward was counterbalanced across mice and across genotype.